{"id":"https://openalex.org/W4406152811","doi":"https://doi.org/10.1080/14737167.2025.2450310","title":"A retrospective observational analysis of the real-world care pathway of people with hereditary transthyretin amyloidosis with polyneuropathy in Italy","display_name":"A retrospective observational analysis of the real-world care pathway of people with hereditary transthyretin amyloidosis with polyneuropathy in Italy","publication_year":2025,"publication_date":"2025-01-08","ids":{"openalex":"https://openalex.org/W4406152811","doi":"https://doi.org/10.1080/14737167.2025.2450310","pmid":"https://pubmed.ncbi.nlm.nih.gov/39773081"},"language":"en","primary_location":{"id":"doi:10.1080/14737167.2025.2450310","doi":"https://doi.org/10.1080/14737167.2025.2450310","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14737167.2025.2450310","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1080/14737167.2025.2450310","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030955374","display_name":"Silvia Calabria","orcid":"https://orcid.org/0000-0001-9345-2855","observed_orcids":["https://orcid.org/0000-0001-9345-2855"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvia Calabria","raw_affiliation_strings":["Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy"],"raw_orcid":"https://orcid.org/0000-0001-9345-2855","affiliations":[{"raw_affiliation_string":"Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","institution_ids":[]},{"raw_affiliation_string":"Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069260022","display_name":"Giulia Ronconi","orcid":"https://orcid.org/0000-0002-5502-8110","observed_orcids":["https://orcid.org/0000-0002-5502-8110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giulia Ronconi","raw_affiliation_strings":["Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy"],"raw_orcid":"https://orcid.org/0000-0002-5502-8110","affiliations":[{"raw_affiliation_string":"Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","institution_ids":[]},{"raw_affiliation_string":"Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037919512","display_name":"Letizia Dondi","orcid":"https://orcid.org/0009-0001-3168-6856","observed_orcids":["https://orcid.org/0009-0001-3168-6856"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Letizia Dondi","raw_affiliation_strings":["Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy"],"raw_orcid":"https://orcid.org/0009-0001-3168-6856","affiliations":[{"raw_affiliation_string":"Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","institution_ids":[]},{"raw_affiliation_string":"Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045472710","display_name":"Leonardo Dondi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonardo Dondi","raw_affiliation_strings":["Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","institution_ids":[]},{"raw_affiliation_string":"Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038721329","display_name":"Irene Dell\u2019Anno","orcid":"https://orcid.org/0000-0003-0782-8823","observed_orcids":["https://orcid.org/0000-0003-0782-8823"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Irene Dell\u2019Anno","raw_affiliation_strings":["Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy"],"raw_orcid":"https://orcid.org/0000-0003-0782-8823","affiliations":[{"raw_affiliation_string":"Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","institution_ids":[]},{"raw_affiliation_string":"Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065904940","display_name":"Carlo Pasquale Piccinni","orcid":"https://orcid.org/0000-0002-8648-8961","observed_orcids":["https://orcid.org/0000-0002-8648-8961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlo Piccinni","raw_affiliation_strings":["Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy"],"raw_orcid":"https://orcid.org/0000-0002-8648-8961","affiliations":[{"raw_affiliation_string":"Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","institution_ids":[]},{"raw_affiliation_string":"Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056067048","display_name":"Immacolata Esposito","orcid":"https://orcid.org/0000-0001-7898-6103","observed_orcids":["https://orcid.org/0000-0001-7898-6103"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Immacolata Esposito","raw_affiliation_strings":["Drugs and Health Srl","Drugs and Health Srl, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drugs and Health Srl","institution_ids":[]},{"raw_affiliation_string":"Drugs and Health Srl, Roma, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063664990","display_name":"Alice Addesi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alice Addesi","raw_affiliation_strings":["Drugs and Health Srl","Drugs and Health Srl, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drugs and Health Srl","institution_ids":[]},{"raw_affiliation_string":"Drugs and Health Srl, Roma, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015073759","display_name":"Marco Gnesi","orcid":"https://orcid.org/0000-0001-6022-6325","observed_orcids":["https://orcid.org/0000-0001-6022-6325"]},"institutions":[{"id":"https://openalex.org/I4210139728","display_name":"AstraZeneca (Italy)","ror":"https://ror.org/04e6qgn10","country_code":"IT","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210139728"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Gnesi","raw_affiliation_strings":["AstraZeneca S.p.A","Medical Evidence, Biopharmaceuticals Medical, AstraZeneca S.p.A, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca S.p.A","institution_ids":[]},{"raw_affiliation_string":"Medical Evidence, Biopharmaceuticals Medical, AstraZeneca S.p.A, Milano, Italy","institution_ids":["https://openalex.org/I4210139728"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020417060","display_name":"Nicola Cosentino","orcid":"https://orcid.org/0000-0002-8628-3106","observed_orcids":["https://orcid.org/0000-0002-8628-3106"]},"institutions":[{"id":"https://openalex.org/I4210139728","display_name":"AstraZeneca (Italy)","ror":"https://ror.org/04e6qgn10","country_code":"IT","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210139728"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicola Cosentino","raw_affiliation_strings":["AstraZeneca S.p.A","Medical Affairs, Biopharmaceuticals Medical, AstraZeneca S.p.A, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca S.p.A","institution_ids":[]},{"raw_affiliation_string":"Medical Affairs, Biopharmaceuticals Medical, AstraZeneca S.p.A, Milano, Italy","institution_ids":["https://openalex.org/I4210139728"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Marco D\u2019Amelio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139728","display_name":"AstraZeneca (Italy)","ror":"https://ror.org/04e6qgn10","country_code":"IT","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210139728"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco D\u2019Amelio","raw_affiliation_strings":["AstraZeneca S.p.A","Value & Access, Biopharmaceuticals, AstraZeneca S.p.A, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca S.p.A","institution_ids":[]},{"raw_affiliation_string":"Value & Access, Biopharmaceuticals, AstraZeneca S.p.A, Milano, Italy","institution_ids":["https://openalex.org/I4210139728"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004019462","display_name":"Nello Martini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nello Martini","raw_affiliation_strings":["Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Health Foundation, Fondazione ReS (Ricerca e Salute)","institution_ids":[]},{"raw_affiliation_string":"Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088186128","display_name":"Aldo Pietro Maggioni","orcid":"https://orcid.org/0000-0003-2764-6779","observed_orcids":["https://orcid.org/0000-0003-2764-6779"]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]},{"id":"https://openalex.org/I4405268080","display_name":"HCF Fondazione ANMCO per il Tuo cuore ETS","ror":"https://ror.org/05qm1vz81","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4405268080"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Aldo Pietro Maggioni","raw_affiliation_strings":["Heart Care Foundation","ANMCO Research Center, Heart Care Foundation, Firenze, Italy","Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy"],"raw_orcid":"https://orcid.org/0000-0003-2764-6779","affiliations":[{"raw_affiliation_string":"Heart Care Foundation","institution_ids":["https://openalex.org/I4405268080"]},{"raw_affiliation_string":"ANMCO Research Center, Heart Care Foundation, Firenze, Italy","institution_ids":["https://openalex.org/I4210095959","https://openalex.org/I4405268080"]},{"raw_affiliation_string":"Fondazione ReS (Ricerca e Salute) \u2013 Research and Health Foundation, Roma, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5038721329"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7856,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.81785403,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"25","issue":"4","first_page":"535","last_page":"542"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/familial-amyloid-polyneuropathy","display_name":"hereditary transthyretin amyloidosis","score":0.996999979019165},{"id":"https://openalex.org/keywords/polyneuropathy","display_name":"polyneuropathy","score":0.9330000281333923},{"id":"https://openalex.org/keywords/tafamidis","display_name":"tafamidis","score":0.8349999785423279},{"id":"https://openalex.org/keywords/patisiran","display_name":"patisiran","score":0.9990000128746033},{"id":"https://openalex.org/keywords/inotersen","display_name":"inotersen","score":0.9990000128746033},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.8790000081062317},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.8640000224113464},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.8379999995231628},{"id":"https://openalex.org/keywords/prevalence","display_name":"prevalence","score":0.5249999761581421},{"id":"https://openalex.org/keywords/italy","display_name":"Italy","score":0.3490000069141388},{"id":"https://openalex.org/keywords/social-security-reimbursement","display_name":"social security reimbursement","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C121157162","wikidata":"https://www.wikidata.org/wiki/Q419999","display_name":"Transthyretin","level":2,"score":0.8583463430404663},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.8097900152206421},{"id":"https://openalex.org/C2775892965","wikidata":"https://www.wikidata.org/wiki/Q1502312","display_name":"Polyneuropathy","level":2,"score":0.7725710272789001},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7242050170898438},{"id":"https://openalex.org/C2779951007","wikidata":"https://www.wikidata.org/wiki/Q816798","display_name":"Amyloidosis","level":2,"score":0.7101585865020752},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.6450377702713013},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.6434854865074158},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.49844837188720703},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.41346997022628784},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3982638120651245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3642292618751526},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.08764353394508362},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001583","descriptor_name":"Benzoxazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001583","descriptor_name":"Benzoxazoles","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007558","descriptor_name":"Italy","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011115","descriptor_name":"Polyneuropathies","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011115","descriptor_name":"Polyneuropathies","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D011115","descriptor_name":"Polyneuropathies","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D011115","descriptor_name":"Polyneuropathies","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D017281","descriptor_name":"Cost of Illness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D028227","descriptor_name":"Amyloid Neuropathies, Familial","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D028227","descriptor_name":"Amyloid Neuropathies, Familial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D028227","descriptor_name":"Amyloid Neuropathies, Familial","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D028227","descriptor_name":"Amyloid Neuropathies, Familial","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D028227","descriptor_name":"Amyloid Neuropathies, Familial","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/14737167.2025.2450310","doi":"https://doi.org/10.1080/14737167.2025.2450310","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14737167.2025.2450310","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},{"id":"pmid:39773081","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39773081","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of pharmacoeconomics & outcomes research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/14737167.2025.2450310","doi":"https://doi.org/10.1080/14737167.2025.2450310","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14737167.2025.2450310","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W2405319848","https://openalex.org/W2542920833","https://openalex.org/W2774176529","https://openalex.org/W2895544912","https://openalex.org/W2912158095","https://openalex.org/W2920082779","https://openalex.org/W2973809551","https://openalex.org/W2994720473","https://openalex.org/W2996947593","https://openalex.org/W3044499018","https://openalex.org/W3132362098","https://openalex.org/W3137913048","https://openalex.org/W3145296972","https://openalex.org/W3149404375","https://openalex.org/W3155662978","https://openalex.org/W3157764750","https://openalex.org/W3164553946","https://openalex.org/W4362474532","https://openalex.org/W4376644504","https://openalex.org/W4376644875","https://openalex.org/W4386861419","https://openalex.org/W4387115393","https://openalex.org/W4387569414","https://openalex.org/W4391293774","https://openalex.org/W4399786673","https://openalex.org/W4403807798"],"related_works":["https://openalex.org/W4412014679","https://openalex.org/W3137913048","https://openalex.org/W4205134348","https://openalex.org/W2994720473","https://openalex.org/W3110799233","https://openalex.org/W3028986517","https://openalex.org/W4417482120","https://openalex.org/W7168921380","https://openalex.org/W6921039043","https://openalex.org/W4409226315"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1,185],"retrospective":[2],"observational":[3],"study":[4,186],"described":[5],"the":[6,9,12,33,86,97,100,125,156,181,206],"epidemiology":[7],"and":[8,83,91,145,198,202],"burden":[10],"on":[11,205],"Italian":[13],"healthcare":[14,40,88,201],"service":[15],"(SSN)":[16],"of":[17,135,180,187,196],"patients":[18,47,109,119,189],"with":[19,23,110,120,190],"polyneuropathy":[20],"(PN)":[21],"associated":[22],"hereditary":[24],"transthyretin":[25],"amyloidosis":[26],"(ATTRv).":[27],"RESEARCH":[28],"DESIGN":[29],"AND":[30],"METHODS:":[31],"From":[32],"Fondazione":[34],"ReS":[35],"(Ricerca":[36],"e":[37],"Salute)":[38],"administrative":[39],"database":[41],"(~5.5":[42],"million":[43],"inhabitants":[44],"in":[45,53,80],"2021),":[46],"were":[48,103,114,117,123,149],"identified":[49,115],"as":[50],"having":[51],"ATTRv-PN":[52,61,111,176,191],"2021":[54,77],"if":[55],"they":[56],"had":[57],"received":[58,138,143,160],"treatments":[59],"for":[60,140,175,178],"under":[62],"SSN":[63,98],"reimbursement":[64],"(i.e.":[65],"tafamidis,":[66],"patisiran,":[67],"or":[68],"inotersen)":[69],"from":[70],"1":[71],"January":[72],"2014":[73],"to":[74,151],"31":[75],"December":[76],"(index":[78],"date":[79],"2021).":[81],"Demographics":[82],"comorbidities":[84,122],"at":[85],"baseline,":[87],"resource":[89],"consumption,":[90],"related":[92],"direct":[93,200],"costs":[94],"reimbursed":[95],"by":[96],"throughout":[99],"one-year":[101],"follow-up":[102],"described.":[104],"RESULTS:":[105],"In":[106],"2021,":[107],"36":[108],"(prevalence:":[112],"7.4/1,000,000)":[113],"(males":[116],"83.3%;":[118],"\u22652":[121],"61.1%;":[124],"mean":[126,168],"age":[127],"was":[128,171],"73":[129],"\u00b1":[130],"8":[131],"years).":[132],"During":[133],"follow-up,":[134],"patients,":[136],"91.7%":[137],"drugs":[139,174],"ATTRv-PN;":[141],">50%":[142],"antiepileptics":[144],"acid":[146],"suppressants;":[147],"22.2%":[148],"admitted":[150],"overnight":[152],"hospitalizations;":[153],"30.6%":[154],"accessed":[155],"emergency":[157],"department;":[158],"97.2%":[159],"local":[161],"outpatient":[162],"specialist":[163],"care.":[164],"The":[165],"per":[166],"patient":[167],"annual":[169],"cost":[170],"\u20ac":[172],"122,017;":[173],"accounted":[177],"94.7%":[179],"total":[182],"expenditure.":[183],"CONCLUSIONS:":[184],"real-world":[188],"showed":[192],"a":[193],"high":[194],"rate":[195],"comorbidities,":[197],"substantial":[199],"economic":[203],"burdens":[204],"SSN.":[207]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-01-08T00:00:00"}